Immunomodulatory drugs in the treatment of multiple myeloma

Y Abe, T Ishida - Japanese Journal of Clinical Oncology, 2019 - academic.oup.com
… The molecular mechanism of action of IMiDs remained unclear for a long time until 2010
when the protein cereblon (CRBN) was identified as a primary direct target. IMiDs binds to …

Understanding the role of T-cells in the antimyeloma effect of immunomodulatory drugs

C D'Souza, HM Prince, PJ Neeson - Frontiers in immunology, 2021 - frontiersin.org
Immunomodulatory drugs (IMiDs) are effective treatments for patients with multiple myeloma.
IMiDs … of the role for T cells in the overall anti-myeloma effects of immunomodulatory drugs. …

Immunomodulatory drugs for the treatment of B cell malignancies

N Ioannou, K Jain, AG Ramsay - International journal of molecular …, 2021 - mdpi.com
… the mechanisms of action of both IMiDs and CELMoDs in CLL and B cell NHL and focus
on their effects on cellular components within the TME—their immunomodulatory activity …

Immunomodulation by polyunsaturated fatty acids: mechanisms and effects

TM Stulnig - International archives of allergy and immunology, 2003 - karger.com
… Though there is no doubt that PUFAs act at a molecular level, a variety of molecular
mechanisms were resolved only recently (fig.1). This review discusses proposed mechanisms of …

Mechanism of immunomodulatory drug resistance and novel therapeutic strategies in multiple myeloma

X Zuo, D Liu - Hematology, 2022 - Taylor & Francis
… to play a key role in the mechanism of drug resistance. This review focuses on the mechanism
of MM resistance to IMiDs and describes some promising drugs to resensitize MM cells to …

Epigenetic drugs as immunomodulators for combination therapies in solid tumors

L Sigalotti, E Fratta, S Coral, M Maio - Pharmacology & therapeutics, 2014 - Elsevier
… The most common molecular mechanisms underlying such alterations are regulatory or
structural defects in various components involved in the biosynthesis and assembly of the …

Folic acid antagonists: antimicrobial and immunomodulating mechanisms and applications

D Fernández-Villa, MR Aguilar, L Rojo - International journal of molecular …, 2019 - mdpi.com
… While its antibacterial mechanism of action is well-stablished (inhibiting bacterial DHPS like
most sulfonamides), there is no data analyzing the molecular mechanism underlying its anti-…

Current advancement of immunomodulatory drugs as potential pharmacotherapies for autoimmunity based neurological diseases

H Ashraf, P Solla, LA Sechi - Pharmaceuticals, 2022 - mdpi.com
… Various studies confirmed the association of genetic changes with numerous
neurodegenerative diseases by investigating the molecular mechanisms of a particular disease. A …

Immunomodulatory drugs in myelodysplastic syndromes

N Galili, A Raza - Expert Opinion on Investigational Drugs, 2006 - Taylor & Francis
molecular mechanism of TNF-α inhibition by the second class of drugs, the immunomodulatory
drugs … class shares more of the activities of the parent drug than the SelCIDs Citation[3,4]. …

A possible molecular mechanism of immunomodulatory activity of bilirubin

H Isogai, N Hirayama - International Journal of Medicinal …, 2013 - Wiley Online Library
… bilirubin possesses potential immunomodulatory properties. In … bilirubin possesses powerful
immunomodulatory activity and … One of the plausible mechanisms of the immunomodulatory